Evaluation of the intravenous magnesium sulfate effect in clinical improvement of patients with acute ischemic stroke.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical neurology and neurosurgery (Dutch-Flemish ed. Print)

• Publication date

  2013-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clineuro.2012.06.001PMID 22749947
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MedScape

  2009cited by this paper
• Magnesium sulfate neither potentiates nor inhibits tissue plasminogen activator‐induced thrombolysis

  2006cited by this paper
• Extending Reperfusion Therapy for Acute Ischemic Stroke: Emerging Pharmacological, Mechanical, and Imaging Strategies

  2005cited by this paper
• Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial.

  2004cited by this paper
• Neurology in Clinical Practice

  2004cited by this paper
• MAGNESIUM SULFATE IN ACUTE STROKE: A RANDOMIZED DOUBLE-BLIND CLINICAL TRIAL

  2004cited by this paper
• Prehospital Neuroprotective Therapy for Acute Stroke: Results of the Field Administration of Stroke Therapy–Magnesium (FAST–MAG) Pilot Trial

  2004cited by this paper
• Protecting the brain: the search for a clinically effective neuroprotective drug for stroke.

  2004cited by this paper
• Neuroprotective therapy for acute ischaemic stroke: down, but not out.

  2004cited by this paper
• Neuroprotective agents for the treatment of acute ischemic stroke

  2003cited by this paper
• Combination Therapy for Ischemic Stroke

  2002cited by this paper
• Adjuvant Treatment With Neuroserpin Increases the Therapeutic Window for Tissue-Type Plasminogen Activator Administration in a Rat Model of Embolic Stroke

  2002cited by this paper
• Intravenous Administration of Magnesium Sulfate in Acute Stroke: A Randomized Double-blind Study

  2001cited by this paper
• The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator–treated stroke (CLASS-T)

  2001cited by this paper
• Neuroprotection for acute stroke: making clinical trials work.

  1999cited by this paper
• Dose optimization of intravenous magnesium sulfate after acute stroke.

  1998cited by this paper
• Calcium and magnesium in drinking water and risk of death from cerebrovascular disease.

  1998cited by this paper
• Low levels of serum ionized magnesium are found in patients early after stroke which result in rapid elevation in cytosolic free calcium and spasm in cerebral vascular muscle cells.

  1997cited by this paper
• Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia.

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke.

  1995cited by this paper
• Blockers of NMDA‐operated channels decrease glutamate and aspartate extracellular accumulation in striatum during forebrain ischaemia in rats

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Acute elevation and recovery of intracellular [Mg2+] following human focal cerebral ischemia

  1993cited by this paper
• 31P-NMR study of transient ischemia in rat hippocampal slices in vitro.

  1993cited by this paper
• Reduction of Infarct Volume by Magnesium after Middle Cerebral Artery Occlusion in Rats

  1991cited by this paper
• Classification and natural history of clinically identifiable subtypes of cerebral infarction.

  1991cited by this paper
• Acetazolamide effect on cerebellar blood flow in crossed cerebral-cerebellar diaschisis.

  1990cited by this paper
• Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat.

  1990cited by this paper
• The pathophysiology of anoxic injury in central nervous system white matter.

  1990cited by this paper
• Effects of polyvalent cations and dihydropyridine calcium channel blockers on recovery of CNS white matter from anoxia.

  1990cited by this paper
• Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats.

  1990cited by this paper
• Magnesium protects against neurological deficit after brain injury.

  1989cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1988cited by this paper
• Magnesium and Cobalt, not Nimodipine, Protect Neurons Against Anoxic Damage in the Rat Hippocampal Slice

  1988cited by this paper
• Tissue‐specific modulation of the mitochondrial calcium uniporter by magnesium ions

  1985cited by this paper
• Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis

  1957cited by this paper

• Magnesium-containing materials for brain and neural repair: advances and perspectives

  2025cites this paper
• Diet and Nutraceuticals for treatment and prevention of primary and secondary stroke: emphasis on nutritional antiplatelet and antithrombotic agents.

  2024cites this paper
• Unlocking the therapeutic capabilities of GPCR in the treatment of ischemic stroke: A translational literature

  2024cites this paper
• European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke

  2024cites this paper
• Magnesium ions and dementia

  2024cites this paper
• Neuroprotective agents in acute ischemic stroke

  2023cites this paper
• Perspectives on the Molecular Mediators of Oxidative Stress and Antioxidant Strategies in the Context of Neuroprotection and Neurolongevity: An Extensive Review

  2022cites this paper
• Neuroprotection in Acute Ischemic Stroke: A Battle Against the Biology of Nature

  2022cites this paper
• Protective Effects of Intravenous Magnesium Sulfate in Stroke Patients Receiving Amiodarone: A Randomized Controlled Trial.

  2021cites this paper
• Collateral Circulation Augmentation and Neuroprotection as Adjuvant to Mechanical Thrombectomy in Acute Ischemic Stroke.

  2021cites this paper
• Investigation of The Effects of Serum Iron and Copper Levels in Ischemic Stroke Disease Development

  2021cites this paper
• [The criteria for effectiveness of reperfusion therapy and neuroprotective therapy in ischemic stroke].

  2021cites this paper
• Research Paper: The Effect of Intravenous Magnesium Sulfate in Improvement of Acute Ischemic Stroke Induced Disability: A Randomized Double Blinded Clinical Trial

  2020cites this paper
• Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions

  2020cites this paper
• Therapeutic Potential of Nutraceuticals to Protect Brain after Stroke.

  2020cites this paper
• DENEYSEL İSKEMİ REPERFÜZYON MODELİNDE GEÇ TROMBOLİTİK TEDAVİ ÖNCESİ MAGNEZYUM SÜLFATIN ETKİNLİĞİ

  2019cites this paper
• Neuroprotective agents in Acute Ischemic Stroke-A Reality Check.

  2019cites this paper
• Intravenous Magnesium Sulfate in Acute Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2019cites this paper
• Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications

  2019cites this paper
• The Effect of Intravenous Magnesium Sulfate in Improvement of Acute Ischemic Stroke Induced Disability: A Randomized Double Blinded Clinical Trial

  2019cites this paper
• Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications

  2019cites this paper
• Low levels of serum magnesium are associated with poststroke cognitive impairment in ischemic stroke patients

  2018cites this paper
• The Role of Magnesium in Neurological Disorders

  2018cites this paper
• Neuroprotective Agents in the Intensive Care Unit

  2018cites this paper
• Evaluation of Serum Magnesium, Iron, Copper and Zinc Levels in Ischemic and Hemorrhagic Stroke Patients and Healthy Controls

  2018cites this paper
• Admission Low Magnesium Level Is Associated with In-Hospital Mortality in Acute Ischemic Stroke Patients

  2017cites this paper
• The role of magnesium sulfate in the intensive care unit

  2017influential citation
• Intraoperative care for aortic surgery using circulatory arrest.

  2017cites this paper
• Reflections on Neuroprotection Research and the Path Toward Clinical Success

  2017cites this paper
• Intake of potassium- and magnesium-enriched salt improves functional outcome after stroke: a randomized, multicenter, double-blind controlled trial.

  2017cites this paper
• Genetic Influences in Traumatic Brain Injury

  2016cites this paper
• Update on anesthetic neuroprotection

  2015cites this paper
• The Effects of Trace Element Deficiencies on Neurological Disease and Treatment with Trace Element Support

  2015cites this paper
• Neuroprotection in Stroke: Past, Present, and Future

  2014cites this paper
• Intraoperative Magnesium Administration Does Not Improve Neurocognitive Function After Cardiac Surgery

  2013cites this paper
• Reactive Oxygen Species-Activated Nanoprodrug of Ibuprofen for Targeting Traumatic Brain Injury in Mice

  2013cites this paper